Member Info for easyp

You could be correct re luck although I think the Romans described luck as a mixture of preparation and opportunity. Another factor in play is simply momentum, go with the flow hence I sold because the sp was falling away and bought some more today on the basis of news and momentum upwards.

Rather than assess, research, buy and hold through thick and thin for years I decided to do things differently with this biotech and stop lossed around 8p as the sp just seemed to be sliding daily. After the sharp drop bought a few thousand at 5p and today on the basis of buying and momentum doubled my stake to a modest 60,000 shares.

There seems to be an art to trading small biotechs which limits your losses yet still permits you to jump back on board if the news/buying and momentum push the sp upwards again. I am nowhere near expert at playing the game and the market makers also make up the rules as they see fit but it is worth considering should you be a fan of investing in small biotechs.

I was delighted to see this as I hold some Sprott Silver and Gold Index and shares in YCA. The Uranium market is warming up and we are well placed to ride the price wave upwards as people like TEPCO start looking to buy more fuel.

Mikey, let's see what the market thinks. I would hope for a 10% rise in sp by cease trading today on the basis of this news.

The stats a bit depressing for me but the RNS today actually makes me a little more optimistic that the sp will recover quickly. Funding a feasibility study important as is the buy back in clause.

Good news yes, but these assay results are hardly spectacular. What does encourage me is as has been pointed out by others here, the shallow horizontal bands of mineralization which can be easily and cheaply mined. Mining costs make a big difference to profitability.

Inclined to agree, sold here months ago but now considering a small stake.

If you could buy 25% of HUR at 2p a share or less....would you consider it a sound or risky punt?
Personally, I would have thought it might attract bidders from other funds.

https://www.lse.co.uk/news/top-news-bhp-in-talks-to-sell-usd15-billion-petroleum-arm-to-woodside-fxwuggh6fs3bky1.html
Frees up some money for BHP to make a bid here,

16 mins since market opened and sp showing 12% up or more? LSE site having a bad hair day again?

Nolo I read this as a further delay and subject to the P1 trial working satisfactorily. That said, not a disaster just a qualified yes from the FDA to P3 pending a short trial.

ESG might drive some orders so here's hoping. Exploration has been in the dumps for some years but that will also change as I believe developing countries will need oil and gas for another 30 years or so. Even in the UK most of the Green Initiatives like EVs will take years to arrive.

For the first time in years I feel positive about POS! That said until my holding turns blue I am not celebrating anything.

Can we have one soon announcing a bid from BHP or the Chinese for 40p a share please?

Not the news I had expected but not bad news either! OK lets see if this generates an alternative revenues stream.

Seav also a good post I would bet on CNE selling on the debt at a discount. At these prices and with oil prices where they are CNE looks a buy to me but as you say DYOR.

Another reassuring update from which I conclude it is simply a matter of investors waiting for the utility companies to start worrying about fuel prices and buying from YCA. Even the ESG market is going to wake up to the need for nuclear power and so more reactors will be built over the next decade. While Thorium is a hypothetical threat to uranium fuel prices until I see a pilot power plant built and generating electricity it is not something I would lose sleep over.

On balance I think Avion has driven the board changes prior to the second attempt at Phase III trials because they want a better team running IMM but the timing leaves me feeling a little uncomfortable. It could also be interpreted as board members not wishing to be held accountable for disappointing news coming from the FDA re the trial.

Hence, holding and watching where the sp goes today.

Interesting business and yet the market unimpressed by the latest RNS. Is this a buying opportunity or part of a longer slide down to single digits?

Very, now assuming HUR continues to produce 9,000 bopd for the next few months at what point is a serious share price re rating called for? Personally I see no reason why this is still trading at sub 5p even 7p a share.